R Sumanth Iyer

2PUBLICATIONS
9CO-AUTHORS
Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Mar 20, 2024
Drug-resistant EGFR mutations promote lung cancer by stabilizing interfaces in ligand-free kinase-active EGFR oligomers.

R Sumanth Iyer, Sarah R Needham, Ioannis Galdadas

|Dec 11, 2020
Cooperation and Interplay between EGFR Signalling and Extracellular Vesicle Biogenesis in Cancer.

Laura C Zanetti-Domingues, Scott E Bonner, R Sumanth Iyer

Pageof 1

Frequent Collaborators

2 joint publications

Laura C Zanetti-Domingues

2 joint publications

Marisa L Martin-Fernandez

1 joint publications

Scott E Bonner

1 joint publications

Veronica Huber

1 joint publications

Sarah R Needham

1 joint publications

Gilbert O Fruhwirth

1 joint publications

Peter J Parker

1 joint publications

Daniel J Rolfe

1 joint publications

Francesco L Gervasio

Frequent Collaborators

2 joint publications

Laura C Zanetti-Domingues

2 joint publications

Marisa L Martin-Fernandez

1 joint publications

Scott E Bonner

1 joint publications

Veronica Huber

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.0K
<em>In Vivo</em> Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

<em>In Vivo</em> Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on : Sep 23, 2021

2.8K
See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.0K
<em>In Vivo</em> Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

<em>In Vivo</em> Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on : Sep 23, 2021

2.8K
See more related videos